Skip to main content

Genomics and Genetic Research in Houston Shaping the Future of Health Care

Published Oct 17, 2019 by A.J. Mistretta

Approximately 9,000 genetic researchers and professionals from nearly 80 countries are in Houston this week for the world’s largest annual conference of the human genomics and genetic research community. 

With Houston institutions leading the way in genetic breakthroughs, it’s clear why the American Society of Human Genetics chose the city for this year’s event. The concentration of researchers and patient data in the Texas Medical Center make Houston a center of discoveries helping shape the future of medicine. 

“As people are seeing in their doctors’ offices every day, we are better than ever at predicting, diagnosing, and treating diseases more precisely than ever,” wrote Leslie Biesecker, president of the American Society of Human Genetics, in an op-ed in the Houston Chronicle this week. “Advances in our understanding of the human genome are giving us crucial insights into how our bodies work and what happens when we get sick.”

Discoveries in Houston help power the global scientific and technology research communities, offering medical progress for patients around the world and help drive the local economy, Biesecker said. 

Houston is already home to researchers at Baylor College of Medicine, Texas A&M University Health Science Center, the University of Texas Health Science Center and the University of Texas MD Anderson Cancer Center, to name just a few of the major institutions. Soon, the Texas Medical Center will join with these institutions to begin work on TMC3, a 30-acre biomedical research campus that will ensure Houston continues to lead on life sciences innovation. 

The study of genomics and genetic research is critical to advancing medical treatment for a host of diseases and illnesses. For example, Biesecker points to work currently underway to build databases of genetic cancer markets.

“Genetic sequencing of cancer tumors is helping not only to more accurately diagnose cancers but also to understand what causes them and what drugs could be used to target them, while efforts to understand family history and risk of cancers allow earlier detection," wrote Biesecker.

Researchers are also examining the genetic keystones of diseases such as cardiovascular disease, autism and dementia.

“To be sure, we have along way to go to realize the benefits of genetic and genomic research for people everywhere,” Biesecker wrote. “Yet approaches are driving novel discoveries across the spectrum of biomedical research and yielding life-changing discoveries.”

Learn more about Houston’s robust biotech and life sciences industry and upcoming events related to the sector. Read Biesecker's full op-ed
 

Related News

Biotechnology

Texas A&M to Build $550 Million Project at TMC

2/20/20
The Texas A&M University System plans to build a $550 million complex in the Texas Medical Center that will house its groundbreaking Engineering Medicine (EnMed) program and provide housing for medical and nursing students in Houston. The 5.5-acre project is one of the university system’s most ambitious to date in Houston. It will include an 18-story academic building for the EnMed program in partnership with Houston Methodist, a 19-story student housing building, and a 30-story medical office building.  Texas A&M University System Chancellor John Sharp said the TMC expansion is designed to meet the medical needs of Texans and provide needed space and facilities both students and professionals.  “Texas A&M’s rise in prominence – especially within the health care arena – is reflected with the aggressive expansion of properties near the Texas Medical Center,” Sharp said. “The Houston medical scene is about to see the benefits of Aggie ingenuity and our dedication to service.” EnMed brings a new concept to the TMC where students work on new ways to solve complicated health problems. Students will complete the requirements for master’s degrees in engineering and doctorates of medicine, while also being required to invent new devices or processes before they graduate. “Today’s landmark announcement by Texas A&M is an incredible investment in Houston’s life science and innovation landscape – and in our future workforce,” said Bob Harvey, President and CEO of the Greater Houston Partnership.  “Texas A&M’s EnMed program fits right into what we are doing in Houston. Our city has long been recognized as a destination for world-class health care and cutting-edge research, thanks to the incredible institutions in the Texas Medical Center,” Harvey said. “Houston is also becoming known as an attractive location for both mature and emerging life science and biotech companies. We are, indeed, becoming the 'third coast' for life sciences.”  Learn more about life sciences and health care in Houston as well as our innovation ecosystem. Read more about this project via the Houston Chronicle.   
Read More
Biotechnology

Texas Medical Center's Bill McKeon Lauds Innovation, Research at State of TMC

10/31/19
Texas Medical Center President and CEO Bill McKeon discussed the positive trajectory of the world’s largest medical complex, which is being driven in large part by innovation, research and the expansion of existing institutions. McKeon delivered the annual State of TMC address in conjunction with the Greater Houston Partnership on October 31.  In his keynote, McKeon gave a snapshot of the future of TMC, starting with developments happening at a few of TMC’s 61 member institutions.  Texas A&M University, for instance, is partnering with Houston Methodist to build an innovative engineering medical school that will offer students the ability to earn a master’s degree or Ph.D. in engineering plus an M.D.  “What’s happening at Texas A&M is powerful,” said McKeon.  The project is expected to be completed by May 2020.  McKeon also noted the University of Houston’s support of medical education with its new College of Medicine. In partnership with HCA Houston Healthcare, UH’s College of Medicine will provide residencies in Texas so graduates can continue to work in the state’s urban and rural communities.  In addition to education programs, many of TMC’s member institutions continue to expand in Houston and across the station. That includes Texas Children's expansion in Austin over the past couple of years, as well as MD Anderson Cancer Center’s new campuses around the greater Houston region.  McKeon explained that TMC’s reach extends beyond our region with its international BioBridge partnerships. The latest, signed with Denmark earlier this month, is a multi-faceted collaboration designed to bolster innovation in digital and telehealth. It also calls for increased emphasis on research and education. The agreement marks TMC’s third such international partnership with the goal of driving the next generation of health and medical advancements.   “These BioBridges are really powerful. Why? Because we tie into the innovation community, and, in doing so, all the startups across the world are coming to the Texas Medical Center,” said McKeon.  McKeon turned the stage over to Lance Black, associate director of the Texas Medical Center’s TMCx accelerator program, to lay out how innovation is driving growth at TMC. “TMC Innovation Institute has become a magnet for global talent,” said Black. “We’re evolving to work more closely with our member institutions to better understand their needs.” According to the Partnership's 2019 Houston Facts report, Texas Medical Center institutions employ more than 106,000 Houstonians, host more than 10 million patient visits a year and generate over $25 billion in direct economic impact. The Texas Medical Center is internationally renowned as home to some of the leading minds in medicine, and thanks to its presence, Houston is at the forefront of advancing life sciences.  The Partnership has been working very closely with Bill McKeon and his team to accelerate efforts to position Houston as the Third Coast for Life Sciences with a focus on developing a robust commercial life sciences industry here in Houston.  There’s been great momentum made on this front, including the development of TMC3. Set to open in 2022, this multi-institutional translational research campus will serve as the cornerstone for biomedical advancements in TMC and beyond. TMC3 will help drive economic growth, bringing more than $5 million into the Houston economy and creating roughly 30,000 jobs. It’ll also be instrumental in growing and advancing Houston’s innovation ecosystem, an area the Partnership has been intensely focused over the past couple of years.  To see McKeon's full address, click here. Learn more about Houston's biotechnology and life science sectors. Click here to learn more about health care in the Houston region. 
Read More

Related Events

Executive Partners